Page last updated: 2024-10-28

lidocaine and Cancer, Second Primary

lidocaine has been researched along with Cancer, Second Primary in 1 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosado Caracena, R1
Uña Orejón, R1
Garrido Ortega, P1
Pérez Andujar, JA1
Criado Jiménez, A1

Other Studies

1 other study available for lidocaine and Cancer, Second Primary

ArticleYear
[Convulsions in the operating room in a man with AIDS].
    Revista espanola de anestesiologia y reanimacion, 2009, Volume: 56, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Acute Disease; AIDS-Related Opportunistic Infections; Anti-HIV A

2009